Participation of reactive oxygen intermediates in the angiotensin II-activated signaling pathways in vascular smooth muscle cells.
Takahashi
T
T
Department of Internal Medicine (First Division), Kobe University School of Medicine, Japan.
Taniguchi
T
T
Okuda
M
M
Takahashi
A
A
Kawasaki
S
S
Domoto
K
K
Taguchi
M
M
Ishikawa
Y
Y
Yokoyama
M
M
D000111:Acetylcysteine / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001013:Aorta, Thoracic; D002227:Carbazoles / Q000494:pharmacology; D000077261:Carvedilol; D002478:Cells, Cultured; D004815:Epidermal Growth Factor / Q000494:pharmacology; D006861:Hydrogen Peroxide / Q000494:pharmacology; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology*; D011412:Propanolamines / Q000494:pharmacology; D051381:Rats; D017382:Reactive Oxygen Species / Q000502:physiology*; D015398:Signal Transduction / Q000187:drug effects* / Q000502:physiology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D000975:Antioxidants; D002227:Carbazoles; D011412:Propanolamines; D017382:Reactive Oxygen Species; D000077261:Carvedilol; D000804:Angiotensin II; D004815:Epidermal Growth Factor; D006861:Hydrogen Peroxide; D013755:Tetradecanoylphorbol Acetate; D000111:Acetylcysteine